Decoding the US-EU Trade Tango: Navigating the Uncertainties and Opportunities As a seasoned observer of global trade dynamics, I’ve been closely monitoring the ongoing negotiations between the United States and the European Union. The potential for a new trade framework is significant, but the path forward is riddled with complexities. Let’s break down the key … Read more
Substandard medications, including critical injectables, pose significant risks. Counterfeit drugs further endanger patients. Published May 25, 2025 | 7:52 PM ⚊ Updated May 25, 2025 | 7:52 PM Representative image of drugs (iStock) Synopsis: The CDSCO has flagged 60 medicines – including eye drops and IV fluids linked to blindness in the US and maternal … Read more
The Bitter Pill of Tariffs: Ireland’s Pharma Dilemma The picturesque town of Westport in County Mayo stands in stark contrast to its grey, factory-dominated skyline. These factories, chiefly producing Botox and other pharmaceuticals, form the economic backbone of Westport. Yet, President Donald Trump’s push for reshoring pharma production casts uncertainty over the 7,000 individuals dependent … Read more
Five years have passed since the World Health Organization declared COVID-19 a pandemic. Today, we look back with a sense of reflection and critique. Virologist Christian Drosten noted in his interview with NDR that communication between politics and science during the pandemic did not function optimally. This underscores the necessity for improved transparency in future … Read more
The Future of Weight-Loss Treatments: Transitioning from Injections to Pills The landscape of weight-loss treatments is undergoing a significant transformation. Companies like Eli Lilly are pioneering efforts to make GLP-1 treatments more accessible worldwide with the introduction of an oral pill, orforglipron. This shift from injections to oral medications promises broader reach and adoption, according … Read more